We next examined the systemic anti-tumor immune response and observed that the number of MUC1-specific IFN-γ-producing cells in the spleen was much higher in the LLC+Py mice compared to the LLC mice (Fig. 6D). The gene discussed is MUC1; the disease is neoplasm.